Physician profile
Alexandra Smith
NPI 1811685506
$2,343.87
in general payments reported to CMS, 2019-2025
13 companies · $1,501 in 2025
The $1,501 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $843 · 2025: $1,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,264 · Education: $80.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,263.60 |
| Education | $80.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $701.36 | 2024-2025 | |
| Abbvie INC. | $529.86 | 2024-2025 | |
| Incyte Corporation | $361.30 | 2024-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $332.16 | 2025 | Dupixent |
| Ucb, INC. | $189.44 | 2025 | Bimzelx |
| Leo Pharma INC. | $43.83 | 2025 | Adbry |
| Janssen Biotech, INC. | $40.53 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $27.41 | 2025 | Sotyktu |
| Amgen INC. | $26.92 | 2025 | Otezla |
| Pfizer INC. | $25.61 | 2024 | |
| Novartis Pharmaceuticals Corporation | $24.86 | 2025 | |
| Sun Pharmaceutical Industries INC. | $21.35 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.24 | 2025 | Jublia, Cabtreo, Siliq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.